Revolution Medicines to Present Updated Phase 1 Clinical Data for Zoldonrasib in Patients with Previously Treated KRAS G12D Non-Small Cell Lung Cancer at the 2026 AACR Annual ...

Summary of Phase 1 Zoldonrasib Data at AACR 2026 ( Abstract # CT021 ) ...

A Long Elusive Lung Cancer Target May Finally Be Yielding to New Drugs

Early results presented at a cancer research conference showed tumor shrinkage and slowed disease progression in patients who ...

Do you need a heart transplant? Experts reveal critical red flags

A heart transplant is a life-saving last resort for advanced heart failure when treatments fail. Key signs include ...

$3 million prize goes to duo whose research led to first sickle cell CRISPR therapy

Dr. Swee Lay Thein and Dr. Stuart Orkin won the $3 million Breakthrough Prize in Life Sciences for their work toward a ...

Nanobody repairs misfolded CFTR inside cells, boosting function in cystic fibrosis

A tiny antibody component could fundamentally transform the treatment of cystic fibrosis: For the first time, researchers ...
Dairy Herd

Hidden Pneumonia in Calves: Why More Dairies are Using Ultrasound to Catch Respiratory Disease Early

Many calves develop pneumonia days before showing symptoms. Lung ultrasounds are helping veterinarians detect the hidden ...
Thorax

Sex-based differences in effectiveness of immune checkpoint inhibitors in the treatment of advanced non-small-cell lung cancer: systematic review and meta-anal…

Background Sex-based differences in immune response are well established, but whether men and women derive comparable benefit ...
The Lancet

Refiloe Masekela: building access to care for childhood lung disease

In the 2000s, when the AIDS pandemic hit South Africa, we were seeing a lot of children dying from HIV. That was just before ...

Long-term cure rates for multidrug-resistant tuberculosis much better than expected

A new national cohort study provides important insights into the treatment of multidrug-resistant tuberculosis (MDR-TB). The ...

First-line targeted therapy shows antitumor activity in patients with advanced lung cancer

First-line zongertinib showed antitumor activity in treatment-naive patients with advanced or metastatic HER2-mutant ...
MedPage Today

Early Lung Cancer Data Show Why FDA Approved HER2 Agent in First-Line

Chemotherapy has been the standard for previously untreated advanced or metastatic HER2-mutant lung cancer. In this phase I ...
WGN-TV

Potential treatment could clear scar tissue from lungs

Scientists think they have discovered the reason pulmonary fibrosis patients get worse and don’t heal. Pulmonary fibrosis leads to scar tissue development in the lungs that persists until patients ...